ImPACT Version 4-Touchscreen: Normative and Reliability Study
NCT ID: NCT05551520
Last Updated: 2023-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1437 participants
INTERVENTIONAL
2022-02-07
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ImPACT Normative Extension
NCT03180905
Concussion Texting Study
NCT03099733
Metacognitive Therapy for Post-concussive Symptoms After Mild Traumatic Brain Injury
NCT02690584
Testing Devices That Involve the Sense of Touch in Subjects With Traumatic Brain Injury
NCT01404494
Perceptual-Cognitive Training After a Mild Traumatic Brain Injury: Towards a Sensitive Marker for Recovery
NCT03213730
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normative
ImPACT will be administered to participant's for a baseline test.
Normative
ImPACT will be administered at baseline testing
Reliability
ImPACT will be administered to participant's within 60 days of baseline test.
Reliability
ImPACT will be administered again within 60 days of baseline test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Normative
ImPACT will be administered at baseline testing
Reliability
ImPACT will be administered again within 60 days of baseline test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Primary English speaking or fluent in English
Exclusion Criteria
2. History of concussion less than 6 months to the study participation
3. Known physical (e.g., visual impairment not fixable by usual means, such as glasses) or psychological impairment (ADHD, LDD, etc.) that would affect their ability to perform the test.
12 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ImPACT Applications, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ImPACT Applications, Inc.
Coralville, Iowa, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QPR-21-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.